Program or Country status Program activity Type model Funding focus Program Population type collection Data Data organism Notifiable Report Region of ANSORP250 Asia Current AMR n/a Organism/infection Community/hospital Susceptibility MRSA n/a resistance testing of S. studies on pneumococcal pneumoniae publications community isolates pneumococcal infections CARTIPS88 Current AMR n/a Organism/ Community/hospital Susceptibility S. n/a resistance infection testing of pneumoniae study of clinical isolates H. influenzae publications against M. catarrhalis antimicrobial K. respiratory agents pneumoniae tract infections MSSA Streptococcus spp. MOHNARIN251 China Current AMR n/a Organism Hospital (ICUs) Susceptibility n/a n/a (129 tertiary surveillance testing of hospitals) studies clinical isolates journal, annual reports CHINET251 China Current AMR n/a Organism Hospital Susceptibility n/a n/a (21 tertiary surveillance testing of hospitals) studies clinical isolates publications; surveillance data does not account for AMR in primary care or community settings
Program Country or Region Program status Type of activity Funding model Program focus Population Data collection type Data Notifiable organism Report ANSORP250 Asia Current AMR resistance studies on community pneumococcal infections n/a Organism/infection Community/hospital Susceptibility testing of pneumococcal isolates MRSA S. pneumoniae n/a publications CARTIPS88 Current AMR resistance study of respiratory tract infections n/a Organism/ infection Community/hospital Susceptibility testing of clinical isolates against antimicrobial agents S. pneumoniae H. influenzae M. catarrhalis K. pneumoniae MSSA Streptococcus spp. n/a publications MOHNARIN251 China (129 tertiary hospitals) Current AMR surveillance studies n/a Organism Hospital (ICUs) Susceptibility testing of clinical isolates n/a n/a journal, annual reports CHINET251 China (21 tertiary hospitals) Current AMR surveillance studies n/a Organism Hospital Susceptibility testing of clinical isolates n/a n/a publications; surveillance data does not account for AMR in primary care or community settings
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx